Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Hunter C Smith

CFO at Rhythm Pharmaceuticals, Inc. (RYTM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.8M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 1SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 23,072153,726 held (−13%) $104.59 $2.4M -13.2%
Sep 1SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 11,514142,212 held (−7%) $105.37 $1.2M -13.8%
Sep 1SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 28,188114,024 held (−20%) $106.20 $3.0M -14.5%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,200117,266 held (−1%) $99.42 $119K -8.7%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 200117,066 held (−0%) $100.52 $20K -9.7%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 900116,166 held (−1%) $101.70 $92K -10.7%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,069115,097 held (−1%) $103.00 $110K -11.9%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 200114,897 held (−0%) $103.84 $21K -12.6%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,308113,589 held (−1%) $100.27 $131K -9.5%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,692111,897 held (−1%) $100.92 $171K -10.0%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 800111,097 held (−1%) $102.10 $82K -11.1%
Feb 19SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 585110,512 held (−1%) $103.28 $60K -12.1%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,913123,624 held (−2%) $102.66 $196K -11.6%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 700122,924 held (−1%) $103.68 $73K -12.4%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 100122,824 held (−0%) $104.76 $10K -13.3%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 2,266120,558 held (−2%) $98.37 $223K -7.7%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 400120,158 held (−0%) $99.44 $40K -8.7%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 100120,058 held (−0%) $100.85 $10K -10.0%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 292119,766 held (−0%) $96.26 $28K -5.7%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 400119,366 held (−0%) $97.67 $39K -7.1%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 800118,566 held (−1%) $98.99 $79K -8.3%
Feb 12SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 100118,466 held (−0%) $100.10 $10K -9.3%
Feb 6SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,500130,665 held (−1%) $104.74 $157K -13.3%
Feb 6SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,000129,665 held (−1%) $106.60 $107K -14.8%
Feb 6SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 747128,918 held (−1%) $107.67 $80K -15.7%
Feb 6SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 3,381125,537 held (−3%) $106.06 $359K -14.4%
  • Sell

    CFO Hunter C Smith sold $2.4M of RYTM at $104.59 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Hunter C Smith sold $1.2M of RYTM at $105.37 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Hunter C Smith sold $3.0M of RYTM at $106.20 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Hunter C Smith sold $119K of RYTM at $99.42 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Hunter C Smith sold $20K of RYTM at $100.52 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Hunter C Smith sold $92K of RYTM at $101.70 — pre-scheduled 10b5-1 plan sale.